Mark G. Edwards, Director at ACELRX PHARMACEUTICALS INC (ACRX), bought 5,000 shares at $3.35 ($17K) on 2018-06-05, disclosed to the SEC on 2018-06-05.
Open-market purchase of $17k ACRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.30 | 300 | $990 | 5.9% |
| 2 | $3.35 | 4,700 | $16K | 94.1% |
| Total | $3.35 avg | 5,000 | $17K | 100% |
| Filing → |
| ACRX | BUY | 2019-03-12 | $114K | — | Filing → |
| ACRX | BUY | 2018-11-15 | $58K | — | Filing → |
| ACRX | BUY | 2018-08-08 | $15K | — | Filing → |